Indication

In combination with cyclophosphamide, doxorubicin and prednisone (CHP) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL).

Medicine details

Medicine name:
brentuximab vedotin (Adcetris)
SMC ID:
SMC2310
Pharmaceutical company
Takeda UK Ltd
BNF chapter
Malignant disease and immunosuppression
Submission type
Full
Publication due date:
11 January 2021
Patient group submission deadline:
02 November 2020